BAY 1075553 PET/CT in staging and restaging of prostate cancer patients - Phase I study and comparison to 18F-FCH

被引：0
|
作者：
Beheshti, Mohsen [1 ]
Langsteger, Werner [1 ]
Sommerhuber, Andreas [2 ]
Steinmair, Martin [1 ]
Wolf, Iris [1 ]
Valencia, Ray [3 ]
Lesche, Ralf [3 ]
Nader, Michael [1 ]
Piert, Morand [4 ]
Loidl, Wolfgang [2 ]
机构：
[1] St Vincents Hosp, PET CT Ctr Linz, Nucl Med & Endocrinol, Linz, Austria
[2] St Vincents Hosp, Urol, Linz, Austria
[3] Bayer Pharma AG, Global Drug Discovery, Berlin, Germany
[4] Univ Michigan Hlth Syst, Div Nucl Med, Radiol, Ann Arbor, MI USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
272
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I Study: BAY 1075553 in Comparison with 18F-FCH PET/CT in Staging and Re-Staging of Prostate Cancer Patients
    Langsteger, W.
    Loidl, W.
    Haim, S.
    Kunit, T.
    Valencia, R.
    Lesche, R.
    Dinkelborg, L.
    Hinterdorfer, S.
    Nader, M.
    Piert, M.
    Beheshti, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S255 - S255
  • [2] BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)
    Mohsen Beheshti
    Thomas Kunit
    Silke Haim
    Rasoul Zakavi
    Christian Schiller
    Andrew Stephens
    Ludger Dinkelborg
    Werner Langsteger
    Wolfgang Loidl
    [J]. Molecular Imaging and Biology, 2015, 17 : 424 - 433
  • [3] BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)
    Beheshti, Mohsen
    Kunit, Thomas
    Haim, Silke
    Zakavi, Rasoul
    Schiller, Christian
    Stephens, Andrew
    Dinkelborg, Ludger
    Langsteger, Werner
    Loidl, Wolfgang
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (03) : 424 - 433
  • [4] 18F-FCH PET/CT Staging in Prostate Cancer
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 30N - +
  • [5] 18F-FCH PET/CT for patients with uremic hyperparathyroidism
    Xue, Yu
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [6] Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy
    Kit, Nicolas How
    Dugue, Audrey E.
    Sevin, Emmanuel
    Allouache, Nedjla
    Lesaunier, Francois
    Joly, Florence
    Aide, Nicolas
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (04) : 348 - 355
  • [7] The study of 18F-FDG and 18F-FCH PET/CT in the clinical evaluation of pancreatic cancer
    Cheng, Bing
    Han, Xingmin
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] Head To Head Comparison Of 18f-fch And 18f-psma-1007 Pet/ct In Biochemically Relapsed Prostate Cancer Patients Preliminary Results
    Witkowska-Patena, E.
    Gizewska, A.
    Dziuk, M.
    Misko, J.
    Budzynska, A.
    Walecka-Mazur, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S446 - S447
  • [9] 18F-FCH-PET/CT in Prostate Cancer Patients
    Nikaki, A.
    Kechagias, D.
    Vlachou, F.
    Fillippi, V.
    Pipikos, T.
    Savvidou, D.
    Dalianis, K.
    Gogos, K.
    Efthymiadou, R.
    Prassopoulos, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S366 - S367
  • [10] 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer
    Witkowska-Patena, Ewa
    Gizewska, Agnieszka
    Misko, Jolanta
    Dziuk, Miroslaw
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E401 - E403
12345